Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202407870029422Phase 1Not yet recruiting
Phase 1, open-label, single-arm trial in Not applicable, sponsored by Institut de Recherche en Sciences de la Santé. Primary endpoints: Adverse events and Biological parameter disturbances. Planned start Jul 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202407870029422.